topotecan has been researched along with Acquired Immunodeficiency Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Apuzzo, L; Chang, L; Concha, M; Dupont, B; Ernst, T; Fish, D; Goodkin, K; McGuire, D; Pailloux, G; Poncelet, H; Post, MJ; Royal, W; Singer, E | 1 |
Smart, T | 1 |
1 trial(s) available for topotecan and Acquired Immunodeficiency Syndrome
Article | Year |
---|---|
Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiretroviral Therapy, Highly Active; Brain; CD4 Lymphocyte Count; Cohort Studies; Drug Administration Schedule; Enzyme Inhibitors; Female; Hematologic Diseases; HIV-1; Humans; Karnofsky Performance Status; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Middle Aged; RNA, Viral; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome; Viral Load | 2003 |
2 other study(ies) available for topotecan and Acquired Immunodeficiency Syndrome
Article | Year |
---|---|
Making inroads on PML.
Topics: Acquired Immunodeficiency Syndrome; Camptothecin; HIV Protease Inhibitors; Humans; Irinotecan; Leukoencephalopathy, Progressive Multifocal; Topotecan | 1996 |
PML update.
Topics: Acquired Immunodeficiency Syndrome; Camptothecin; Clinical Trials, Phase II as Topic; Enzyme Inhibitors; Humans; Leukoencephalopathy, Progressive Multifocal; Topotecan | 1997 |